Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Rev. bras. cir. cardiovasc ; 35(3): 392-395, May-June 2020. tab, graf
Article Dans Anglais | LILACS, SES-SP | ID: biblio-1137260

Résumé

Abstract Coronary fistulas are rare anomalies that can affect approximately 1% of the population, presenting few specific symptoms, and are often found occasionally in coronary angiography. Here we describe the case of a 61-year-old patient with complaints of precordialgia and dyspnea since adolescence, with late diagnosis of coronary fistulas with drainage to the pulmonary artery, and with unsuccessful percutaneous treatment. Therefore, she underwent open surgery for the correction of the already known fistulas, in addition to the hemangioma involving such vessels, which made the understanding and resolution of this case more complex.


Sujets)
Humains , Femelle , Adulte d'âge moyen , Fistule artérioartérielle/chirurgie , Fistule artérioartérielle/imagerie diagnostique , Artère pulmonaire/chirurgie , Artère pulmonaire/imagerie diagnostique , Coronarographie
2.
Rev. Soc. Bras. Clín. Méd ; 17(2): 110-112, abr.-jun. 2019. ilus., tab.
Article Dans Portugais | LILACS | ID: biblio-1026531

Résumé

A vasculopatia livedoide é uma doença rara caracterizada pela oclusão da microvasculatura da derme, originando lesões maculosas que, posteriormente, podem evoluir para úlceras e cicatrizes atróficas. Como um fenômeno vaso-oclusivo, o tratamento geralmente é realizado com antiplaquetários e fibrinolíticos. O presente relato descreve o caso de uma paciente refratária à terapia convencional, que obteve regressão da doença utilizando a rivaroxabana, um fármaco inibidor seletivo do fator Xa. (AU)


Livedoid vasculopathy is a rare disease characterized by occlusion of the dermis microvasculature, leading to spotted lesions that can later develop into ulcers and atrophic scars. As a vaso- occlusive phenomenon, treatment is usually performed with antiplatelet and fibrinolytic agents. The present report describes the case of a female patient refractory to conventional therapy who presented disease remission using rivaroxaban, a selective factor Xa inhibitor drug. (AU)


Sujets)
Humains , Femelle , Adulte d'âge moyen , Thrombose/traitement médicamenteux , Dermatoses vasculaires/traitement médicamenteux , Microangiopathies thrombotiques/traitement médicamenteux , Rivaroxaban/usage thérapeutique , Vasculopathie livédoïde , Paresthésie , Pentoxifylline/usage thérapeutique , Polyneuropathies/diagnostic , Thrombose/complications , Vasodilatateurs/usage thérapeutique , Biopsie , Antiagrégants plaquettaires/usage thérapeutique , Nifédipine/usage thérapeutique , Fibromyalgie , Dermatoses vasculaires/complications , Dermatoses vasculaires/diagnostic , Maladies du tissu conjonctif/complications , Membre inférieur/traumatismes , Électromyographie , Microangiopathies thrombotiques/complications , Inhibiteurs du facteur Xa/usage thérapeutique , Pied/anatomopathologie , Maladies diverticulaires , Fumeurs , Gabapentine/usage thérapeutique , Analgésiques/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche